These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency. Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003 [TBL] [Abstract][Full Text] [Related]
4. Detection of Epstein-Barr virus genome and latent infection gene expression in normal epithelia, epithelial dysplasia, and squamous cell carcinoma of the oral cavity. Kikuchi K; Noguchi Y; de Rivera MW; Hoshino M; Sakashita H; Yamada T; Inoue H; Miyazaki Y; Nozaki T; González-López BS; Ide F; Kusama K Tumour Biol; 2016 Mar; 37(3):3389-404. PubMed ID: 26449822 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study. Leong IT; Fernandes BJ; Mock D Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266 [TBL] [Abstract][Full Text] [Related]
6. The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer. Pang MF; Lin KW; Peh SC Cell Mol Biol Lett; 2009; 14(2):222-47. PubMed ID: 19082921 [TBL] [Abstract][Full Text] [Related]
7. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. Rowe M; Lear AL; Croom-Carter D; Davies AH; Rickinson AB J Virol; 1992 Jan; 66(1):122-31. PubMed ID: 1309242 [TBL] [Abstract][Full Text] [Related]
8. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas. Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472 [TBL] [Abstract][Full Text] [Related]
9. Enhanced PD-L1 Expression in LMP1-positive Cells of Epstein-Barr Virus-associated Malignant Lymphomas and Lymphoproliferative Disorders: A Single-cell Resolution Analysis With Multiplex Fluorescence Immunohistochemistry and In Situ Hybridization. Kume A; Shinozaki-Ushiku A; Kunita A; Kondo A; Ushiku T Am J Surg Pathol; 2022 Oct; 46(10):1386-1396. PubMed ID: 35605962 [TBL] [Abstract][Full Text] [Related]
10. The importance of epigenetic alterations in the development of epstein-barr virus-related lymphomas. Takacs M; Segesdi J; Banati F; Koroknai A; Wolf H; Niller HH; Minarovits J Mediterr J Hematol Infect Dis; 2009 Nov; 1(2):e2009012. PubMed ID: 21416002 [TBL] [Abstract][Full Text] [Related]
11. A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA. Majerciak V; Yang W; Zheng J; Zhu J; Zheng ZM J Virol; 2019 Jan; 93(2):. PubMed ID: 30355690 [TBL] [Abstract][Full Text] [Related]
13. EBV Association with Lymphomas and Carcinomas in the Oral Compartment. Ward BJH; Schaal DL; Nkadi EH; Scott RS Viruses; 2022 Dec; 14(12):. PubMed ID: 36560704 [TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus interactions with the Bcl-2 protein family and apoptosis in human tumor cells. Fu Q; He C; Mao ZR J Zhejiang Univ Sci B; 2013 Jan; 14(1):8-24. PubMed ID: 23303627 [TBL] [Abstract][Full Text] [Related]
15. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Chiang AK; Tao Q; Srivastava G; Ho FC Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153 [TBL] [Abstract][Full Text] [Related]
17. The Role of Epstein-Barr Virus in Modulating Key Tumor Suppressor Genes in Associated Malignancies: Epigenetics, Transcriptional, and Post-Translational Modifications. Fierti AO; Yakass MB; Okertchiri EA; Adadey SM; Quaye O Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053275 [TBL] [Abstract][Full Text] [Related]
19. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation. Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE mBio; 2020 Oct; 11(5):. PubMed ID: 33109754 [TBL] [Abstract][Full Text] [Related]
20. Characteristics of Epstein-Barr virus associated childhood non-Hodgkin's lymphoma in the Republic of Korea. Kim D; Ko Y; Suh Y; Koo H; Huh J; Lee W Virchows Arch; 2005 Sep; 447(3):593-6. PubMed ID: 15991005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]